| Financial Year |
March 31 2023 |
| Monetary Funds |
779,885,608.20 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
14,458,198.99 |
| Accounts Receivable |
824,482,554.91 |
| Advances to Suppliers |
53,935,038.38 |
| Other Receivables |
107,254,111.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
169,425,502.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,654,884.13 |
| Total Current Assets |
1,963,095,898.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,897,076.23 |
| Investment Properties |
-- |
| Fixed Assetes |
1,838,122,416.03 |
| Under-construction Projects |
557,387,858.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
262,696,304.47 |
| R&D expenses |
-- |
| Goodwill |
884,104,800.06 |
| Long-Term Deferred and Prepaid Expenses |
63,087,714.72 |
| Deferred Income Tax Assets |
146,317,293.19 |
| Other Non-Current Assets |
21,775,086.71 |
| Sub-Total of Non-Current Assets |
3,869,851,998.23 |
| Total Assets |
5,832,947,896.71 |
| Short-Term Loans |
683,058,762.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
40,787,533.08 |
| Accounts Payable |
1,113,786,809.27 |
| Accounts Received In Advance |
48,192,529.90 |
| Employee Compensation Payable |
118,219,761.94 |
| Taxes Payable |
50,125,383.76 |
| Interest Payable |
6,202,867.62 |
| Dividend Payable |
6,176.00 |
| Other payables |
562,517,412.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
740,631,475.28 |
| Other Current Liabilities |
113,591.53 |
| Sub-Total of Current Liabilities |
3,359,893,781.46 |
| Long-term Loans |
280,553,331.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
54,497,720.17 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,520,336.00 |
| Deferred Income Tax Liabilities |
44,478,368.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
424,666,248.50 |
| Total Liabilities |
3,784,560,029.96 |
| Paid-In Capital(Or Share Stock) |
3,381,758,753.00 |
| Capital Surplus |
1,567,105,066.30 |
| Surplus Reserve |
129,454,641.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,071,790,285.37 |
| Minority Stockholder's Interest |
41,859,691.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,006,528,175.47 |
| Owner's Equity（Stockholder's Equity） |
2,048,387,866.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,832,947,896.71 |
